139 related articles for article (PubMed ID: 33506898)
1. LINC00641 regulates prostate cancer cell growth and apoptosis via the miR-365a-3p/VGLL4 axis.
Liu WH; Lu JJ; Yu RK; Zhou L; Yu Q; Li DF; Zhu QH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):108-115. PubMed ID: 33506898
[TBL] [Abstract][Full Text] [Related]
2. LINC00641 regulates autophagy and intervertebral disc degeneration by acting as a competitive endogenous RNA of miR-153-3p under nutrition deprivation stress.
Wang XB; Wang H; Long HQ; Li DY; Zheng X
J Cell Physiol; 2019 May; 234(5):7115-7127. PubMed ID: 30378116
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA LINC00641 promotes cell growth and migration through modulating miR-378a/ZBTB20 axis in acute myeloid leukemia.
Wang J; Liu ZH; Yu LJ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7498-7509. PubMed ID: 31539138
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HOXA11-AS promotes cell growth by sponging miR-24-3p to regulate JPT1 in prostate cancer.
Cheng Y; Xiong HY; Li YM; Zuo HR; Liu Y; Liao GL
Eur Rev Med Pharmacol Sci; 2021 Jul; 25(14):4668-4677. PubMed ID: 34337714
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA LINC00173 serves as sponge for miR-338-3p to promote prostate cancer progression via regulating Rab25.
Hu CH; Yang XJ; Yu L; Wang LY; Zhao XC; Han CH
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9290-9302. PubMed ID: 33015770
[TBL] [Abstract][Full Text] [Related]
6. LINC00641 hinders the progression of cervical cancer by targeting miR-378a-3p/CPEB3.
Zhang Y; Yu R; Li L
J Gene Med; 2020 Sep; 22(9):e3212. PubMed ID: 32367630
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade.
Li Z; Hong S; Liu Z
Biochem Biophys Res Commun; 2018 Sep; 503(3):1825-1829. PubMed ID: 30060954
[TBL] [Abstract][Full Text] [Related]
8. The lncRNA MEG3/miR-16-5p/VGLL4 regulatory axis is involved in etoposide-induced senescence of tumor cells.
Tao Y; Yue P; Miao Y; Gao S; Wang B; Leng SX; Meng X; Zhang H
J Gene Med; 2021 Feb; 23(2):e3291. PubMed ID: 33141998
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
Xiao S; Song B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.
Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
[TBL] [Abstract][Full Text] [Related]
12. Long intergenic noncoding RNA 00641 inhibits breast cancer cell proliferation, migration, and invasion by sponging miR-194-5p.
Mao Q; Lv M; Li L; Sun Y; Liu S; Shen Y; Liu Z; Luo S
J Cell Physiol; 2020 Mar; 235(3):2668-2675. PubMed ID: 31490021
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of LncRNA SNHG7 inhibited epithelial-mesenchymal transition in prostate cancer though miR-324-3p/WNT2B axis in vitro.
Han Y; Hu H; Zhou J
Pathol Res Pract; 2019 Oct; 215(10):152537. PubMed ID: 31324390
[TBL] [Abstract][Full Text] [Related]
14. lncRNA OGFRP1 functions as a ceRNA to promote the progression of prostate cancer by regulating SARM1 level via miR-124-3p.
Yan K; Hou L; Liu T; Jiao W; Ma Q; Fang Z; Zhang S; Song D; Liu J; Gao X; Fan Y
Aging (Albany NY); 2020 May; 12(10):8880-8892. PubMed ID: 32428870
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA SNHG14 promotes malignancy of prostate cancer by regulating with miR-5590-3p/YY1 axis.
Luo ZF; Peng Y; Liu FH; Ma JS; Hu G; Lai SL; Lin H; Chen JJ; Zou GM; Yan Q; Sui WG
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4697-4709. PubMed ID: 32432733
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
Li X; Han X; Wei P; Yang J; Sun J
Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CCAT1 promotes prostate cancer cells proliferation, migration, and invasion through regulation of miR-490-3p/FRAT1 axis.
Cai X; Dai Y; Gao P; Ren G; Cheng D; Wang B; Wang Y; Yu J; Du Y; Wang X; Xue B
Aging (Albany NY); 2021 Jul; 13(14):18527-18544. PubMed ID: 34319909
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA long intergenic non-coding 00641 mediates cell progression with stimulating cisplatin-resistance in osteosarcoma cells via microRNA-320d/myeloid cell leukemia-1 axis.
Tang J; Zhu Z; Dong S; Wang Y; Wang J; Chen H; Duan G
Bioengineered; 2022 Mar; 13(3):7238-7252. PubMed ID: 35266447
[TBL] [Abstract][Full Text] [Related]
19. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
[TBL] [Abstract][Full Text] [Related]
20. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
